{"issuance_frequency":"","notes_translated":{"fr":"Les lignes directrices pour gérer les drogues destinées aux essais cliniques sur des sujets humains. Le promoteur doit veiller à ce que l’essai clinique soit mené en conformité avec le protocole qui a été autorisé par Santé Canada et approuvé par le ou les comité(s) d’éthique de la recherche.","en":"Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s)."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2531e080-bf87-4ef5-a1fd-2ad345bec22b","metadata_created":"2020-04-07T19:30:55.487933","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-04-07T19:30:55.487941","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-04-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["pandémie de COVID-19","drogues destinées aux essais cliniques sur des sujets humains","comités d’éthique de la recherche."],"en":["COVID-19 pandemic","drugs for clinical trials involving human subjects","Research Ethics Board (REB)."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2531e080-bf87-4ef5-a1fd-2ad345bec22b","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"55014ccf-0a4c-4471-a474-1212ac5428b9","related_relationship":"","name_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","language":["en"],"created":"2020-04-07T19:30:55.587864","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html","last_modified":null,"position":0,"revision_id":"9f4743e0-c8b6-45cf-b7be-cc7ad2956ac1","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2531e080-bf87-4ef5-a1fd-2ad345bec22b","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5aec93a0-6a92-4694-bdbe-f8796ffa9259","related_relationship":"","name_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","language":["fr"],"created":"2020-04-07T19:30:55.587871","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/gestion-essai-clinique-pendant-pandemie-covid-19.html","last_modified":null,"position":1,"revision_id":"9f4743e0-c8b6-45cf-b7be-cc7ad2956ac1","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-03-23 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"2531e080-bf87-4ef5-a1fd-2ad345bec22b","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","revision_id":"9f4743e0-c8b6-45cf-b7be-cc7ad2956ac1"}